UNSPSC 51294412: Trazodone

This classification denotes an antidepressant agent with the molecular formula C19H22ClN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YBK48BXK30, chemically known as 1,2,4-triazolo(4,3-a)pyridin-3(2h)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)- but generally known as trazodone, which bears US NIH Compound Identifier 5533. European Medicines Agency schedules Trazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11224MIG.

UNSPSC 51294412 Trazodone is a Commodity code nominally identifying a specific antidepressant medication, but recent state and local procurement activity under this code shows little direct purchasing of trazodone itself. Instead, the three most recent opportunities tagged to this code involve broader pharmaceutical procurement — naloxone and drug deactivation systems for emergency harm-reduction programs, direct-to-manufacturer prescription supply chains, and cooperative purchasing frameworks for generic multi-source pharmaceuticals and OTC products. The scope divergence suggests the code may be misfiled in current opportunities or functions as a catchall for pharmaceutical procurement that does not map cleanly to individual drug identifiers. Issuing bodies include county health departments (Seminole County, Florida), state health authorities (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The mix indicates pharmaceutical procurement spans health departments, pharmacy benefit programs, and shared-services purchasing vehicles rather than single-agency bulk drug procurement.

Recent activity centers in Florida, Texas, and the Upper Midwest. Seminole County issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building, with a two-year initial term and one-year renewal option. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) to gather vendor capability information on direct-to-manufacturer prescription supply models for state employee and retiree pharmacy benefits, signaling early-stage strategic sourcing rather than immediate procurement. The Minnesota Multistate Cooperative Purchasing Alliance released an RFP (S1070000015802, due March 26, 2026) for generic pharmaceuticals and OTC products through three authorized wholesalers — AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson — with awards effective July 1, 2026, and a two-year contract term. Pricing evaluations weighted price competitiveness at 75 percent, with 3 percent administrative fees, and vendors must comply with cGMP and Drug Supply Chain Security Act requirements.